9
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Structure/Function Aspects of Neutral P1 Residue Peptide Inhibitors of Thrombin

, &
Pages 29-41 | Received 18 May 1994, Accepted 09 Aug 1994, Published online: 27 Sep 2008

References

  • Magnusson S. The Enzymes, 3rd edn., P. D. Boyer. Academic Press, New York 1972; vol 3: 277–321
  • Lundblad R. L., Kingdon A S., Mann K. G. Meth. Enzymol. 1976; 45: 156–176
  • Chang J.-Y. Eur. J. Biochem. 1985; 151: 217–224
  • Powers J. C., Kam C.-M. Thrombin Structure and Function, L. J. Berliner. Plenum Press, New York 1992; 117–158
  • Wang C.-L.J., Taylor T. L., Mical A. J., Spitz S., Reilly T M. Tet. Lett. 1992; 33: 7667–7670
  • Cheng L., Goodwin C. A., Scully M. F., Kakkar V. V., Claeson G. Tet. Lett. 1991; 32: 7333–7336
  • Cheng L., Goodwin C. A., Scully M. F., Kakkar V. Y., Claeson G. Peptides, Chemishy and Biology, J. A. Smith, J. E. Rivier. Escom, Leiden 1992; 822–823, Ends
  • Kakkar V., Deadman J. J., Claeson G., Cheng L., Chino N., Elgendy E., Scully M. E., Patent W09207869, 1991
  • Claeson G., Cheng L., Chino N, Deadman J., Elgendy S., Kakkar V. V., Scully M. F., Phillip M., Lundin R., Mattson C. Peptides, Chemisty and Biology, J. A. Smith, J. E. Rivier. Escom, Leiden 1992; 824–825
  • Claeson G., Phillip M., Agner E., Scully M. F., Metternich R., Kakkar V V, DeSoyza T, Niu L.-H. Biochem. J. 1993; 290: 309–312
  • Scully M. F. Essays in Biochemistry, vol 27, K. F. Tipton. Portland press Chapel Hill, London 1992; 17–36
  • Scully M. F. Semin. Thromb. Hemost. 1992; 18: 218–223
  • Mehdi S. Bioorg. Chem. 1993; 21: 249–255
  • Bajusz S., Szell E., Bagdy D., Barabas E., Horvath G., Dioszegi M., Fittler Z., Szabo G., Juhasz A., Tbmori E., Szilagyi G. J. Med. Chem. 1990; 33: 1729–1735
  • Angelastro M. R., Mehdi S., Burkhrt J. P., Peet N. P., Bey P. J. Med. Chem. 1990; 33: 13–16
  • Ocain T D., Rich H. R. J. Med. Chem. 1992; 35: 451–456
  • Neises B., Tarnus C., Broersma R. J., Bald C., Remy J. M., Heminger E. F. The Design of Synthetic Inhibitors of Thrombin, G. Claeson, M. F. Scully, V. V Kakkar, J. Deadman. Plenum Press, N.Y. 1993; vol. 340: 185–188
  • Phillip M., Niua L.-H., DeSoyza T., Claeson G., Metternich R. The Design of synthetic Inhibitors of Thrombin, G. Claeson, M. F. Scully, V. V. Kakkar, J. Deadman. Plenum Press, N.Y. 1993; vol. 340: 67–78
  • Baldwin J. E., Calridge T. D.W., Derome A. E., Smith B. D., Twyman M., Waley S. G. J. Chem. Soc. Chem. Commun. 1991; 8: 573–574
  • Baldwin J. E., Claridge T. W.E., Derome A. E., Schofield C. J., Smith B. D. Bioog. Med. Chem. Lett. b 1991; 7(1)9–12
  • Bone R., Shenvi A. B., Kettner C. A., Agard P. A. Biochemistry 1987; 26: 7609–7614
  • Bachovchin W. W., Wong W. Y.L., Farr-Jones S., Shenvi A. B., Kettner C. A. Biochemists 1988; 27: 7689–7697
  • Takahashi L. H., Radhakrishnan R., Rosenfield R. E., Jr, Meyer E. F., Jr. Biochemistry 1989; 28: 7610–7617
  • Bone R., Sampson N., Bartlett P. A., Agard D. A. Biochemistry 1991; 30: 2263–2272
  • Bode W., personal communication
  • Tsilikounas E., Kettner C. A., Bachovchin W. W. Biochemistry 1992; 31: 12839–12846
  • Tsilikounas E., Kettner C. A., Bachovchin W. W. Biochemistry 1993; 32: 1251–1255
  • Kettner C. A., Shenvi A. B. J. Biol. Chem. 1994; 259: 5106–15114
  • Stone P J., Lucey E. C., Snider G. L. Am. Rev. Respir: Dis. 1990; 141: 47–52
  • Soskel N. T., Watanabe S., Hardie R., Shenvi A. B., Punt J. A., Kettner C. A. Am. Rev. Respir. Dis. 1986; 133: 635–638
  • Soskel N. T., Watanabe S., Hardie R., Shenvi A. B., Punt J. A., Kettner C. A. Am. Rev. Respir: Dis. 1986; 133: 638–642
  • Kettner C., Mersinger L., Knabb R. J. Biol. Chem. 1990; 265: 18289–18297
  • Bode W., Mayr I., Baumann U., Huber R., Stone S. R., Hofsteenge J. EMBO. J. 1989; 8: 3467–3475
  • Bode W., Turk D., Karshikov A. Protein Science 1992; 1: 426–471
  • Stubbs M. T., Bode W. 'Thromb. Res. 1993; 69: 1–58
  • Matteson D. S., Jestni P. K., Sadhu K. M. Organometallics 1984; 3: 1284–1288
  • Elgendy S., Deadman J., Patel G, Green D., Chinos N., Goodwin C. A., Scully M. F., Kakkar V. V., Claeson G. Tet. Lett. 1992; 33: 4209–4212
  • Elgendy S., Claeson G., War V. V., Green D., Patel Goodwin C.A., Baban J. A., Scully M. F., Deadman J. Tetrahedron 1994; 50: 3803–3812
  • Elgendy S., Patel G., Kakkar V. V., Claeson G., Green D., Skordalakes E., Baban J., Deadman J. Tet. Lett. 1994; 35: 2435–2436
  • Gladner J. A., Laki K. J. Am. Chem. Soc. 1958; 80: 1263–1264
  • Powers J. C., Oleksyszyn J. Biochem. Biophys. Res. Commun. 1989; 161: 143–149
  • Green D., Patel G., Elgendy S., Baban J. A., Claeson G., Kakkar V. V., Deadman J. Tet. Lett. 1993; 34: 6917–4920
  • Green D., Patel G., Elgendy S., Baban J., Claeson G., Kakkar V. V., Deadman J. Tetrahedron 1994; 50: 5099–5108
  • Cha S. Biochem. Pharmacol. 1975; 24: 2177–2185
  • Hijikata-Okunomiya A., Okamoto S. Semin. Thromb. Hemost. 1992; 18: 135–149
  • Okamoto S., Wanaka K., Hijikata-Okunomiya A. The Design of Synthetic Inhibitors of Thrombin, G. Claeson, M. F. Scully, V. V. Kakkar, J. Deadman. Plenum Press, N.Y. 1993; vol. 340: 119–130
  • Kaiser B., Hauptmann J. Cardiovascular Drug Rev. 1992; 10: 71–87
  • Bush L. R. Cardiovascular Drug Rev. 1991; 9: 247–263
  • Mattson C. H., Erikssn E., Nilsson S. Folica Haematol. Leipzig 1982; 109: 43–51
  • Brundish D. E. Current Drugs 1992; 9: 1457–1466

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.